Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Pakistan Journal of Biological Sciences
  Year: 2014 | Volume: 17 | Issue: 4 | Page No.: 582-585
DOI: 10.3923/pjbs.2014.582.585
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Assessing Validity of Serum Cystatin C for Predicting Metabolic Syndrome

Zahra Asefy, MirMoosa Mirinejad, Hooshang Amirrasooli and Mohammad Tagikhani

Abstract:
Serum concentration of cystatin C a marker of glomerular filtration has been associated with Cardiovascular Disease (CVD). The aim of this study was to evaluate cystatin C as a marker of diabetic kidney disease in normoalbuminuric diabetic patients without Chronic Kidney Disease (CKD). The study population consisted of 65 subjects with metabolic syndrome and 32 subjects free of metabolic syndrome (control group). HDL-C, LDL-C, blood urea, triglycerides, glucose, HbA1c, serum cystatin C and serum creatinine were measured in both groups. GFR was calculated in both groups using Cockrofta Gault equation. Metabolic syndrome presented higher cystatin C levels than normal samples (0.98 8 0.26 1.24 8 0.24 p<0.05). In the binary logistic regression, the presence of diabetes and metabolic syndrome was significantly associated with elevated cystatin C levels. Diabetic patients also presented a slightly greater creatinine (1.11 8 0.09 1.04 0.15 p<0.05). The results suggest that cystatin C may be a marker for metabolic syndrome and may identify a certain degree of renal dysfunction even when serum creatinine does not exceed normal level.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Zahra Asefy, MirMoosa Mirinejad, Hooshang Amirrasooli and Mohammad Tagikhani, 2014. Assessing Validity of Serum Cystatin C for Predicting Metabolic Syndrome. Pakistan Journal of Biological Sciences, 17: 582-585.

DOI: 10.3923/pjbs.2014.582.585

URL: https://scialert.net/abstract/?doi=pjbs.2014.582.585

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 

Curve Bottom